---
layout: post
title: "Notice of Product Exclusion Extensions: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation"
date: 2026-02-05 18:55:34 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-10460
original_published: 2023-05-17 00:00:00 +0000
significance: 8.00
---

# Notice of Product Exclusion Extensions: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation

**Published:** February 05, 2026 18:55 UTC
**Source:** Federal Register
**Original Published:** May 17, 2023 00:00 UTC
**Document Number:** 2023-10460

## Summary

In prior notices, the U.S. Trade Representative modified the actions in the Section 301 investigation of China's acts, policies, and practices related to technology transfer, intellectual property, and innovation by excluding from additional duties certain medical-care products needed to address COVID, and subsequently extended certain of these exclusions. The current COVID exclusions--covering 81 medical- care products--are scheduled to expire on May 15, 2023. This notice announces the U.S. Trade Representative's determination to provide a 16-day transition period for all COVID exclusions, extending them through May 31, 2023, and to extend 77 of the COVID exclusions through September 30, 2023.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/05/17/2023-10460/notice-of-product-exclusion-extensions-chinas-acts-policies-and-practices-related-to-technology)
- API: https://www.federalregister.gov/api/v1/documents/2023-10460

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
